Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Equity Ratio (2022 - 2026)

Core Laboratories filings provide 5 years of Equity Ratio readings, the most recent being 0.47 for Q1 2026.

  • On a quarterly basis, Equity Ratio rose 8.08% to 0.47 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.47, a 8.08% increase, with the full-year FY2025 number at 0.46, up 5.62% from a year prior.
  • Equity Ratio hit 0.47 in Q1 2026 for Core Laboratories, up from 0.46 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.47 in Q1 2026 to a low of 0.3 in Q2 2022.
  • Median Equity Ratio over the past 5 years was 0.4 (2024), compared with a mean of 0.4.
  • Biggest five-year swings in Equity Ratio: increased 21.27% in 2023 and later grew 5.62% in 2025.
  • Core Laboratories' Equity Ratio stood at 0.32 in 2022, then increased by 20.58% to 0.38 in 2023, then rose by 12.69% to 0.43 in 2024, then increased by 5.62% to 0.46 in 2025, then rose by 2.79% to 0.47 in 2026.
  • The last three reported values for Equity Ratio were 0.47 (Q1 2026), 0.46 (Q4 2025), and 0.46 (Q3 2025) per Business Quant data.